Internal Medicine Doctors in Newton, KS Accepting Medicare

8 Internal Medicine doctors found. Showing 1 - 8

Dwight E Wheeler, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 720 Medical Center Dr, Newton, KS 67114 Phone: 316-284-5150    Fax: 316-284-5110

Dr. Terence Aik-huang Tan, M.B. B.CH. B.A.O. Internal Medicine - Medical Oncology Medicare: Not Enrolled in Medicare Practice Location: 730 Medical Center Dr, Newton, KS 67114 Phone: 316-283-1141    Fax: 316-283-1162

Jan M Hoffman, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 700 Medical Center Dr, Suite 140, Newton, KS 67114 Phone: 316-804-6100    Fax: 316-804-6123

Dr. Marnie Van Becelaere, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 301 N Main St, Ste 300, Newton, KS 67114 Phone: 316-282-9614    Fax: 316-284-9602

Stephanie L Gibson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Medical Center Dr, Newton, KS 67114 Phone: 316-283-2700

Dr. Robert R Roeser, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 715 Medical Center Dr, Suite 200, Newton, KS 67114 Phone: 316-283-6655

Dr. Gregory D Nanney, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 730 Medical Center Dr, Newton, KS 67114 Phone: 316-283-1141    Fax: 316-283-1162

Dr. Elshami M Elamin, MD Internal Medicine - Medical Oncology Medicare: Accepting Medicare Assignments Practice Location: 730 Medical Center Dr, Newton, KS 67114 Phone: 316-283-1141    Fax: 316-283-1162

News Archive

AGTC receives grant to evaluate Phase II Human Clinical Trial for LCA retinal disease

Applied Genetic Technologies Corporation, a privately-held, clinical stage biotechnology company developing novel systems to deliver human therapeutics, announces that it has received a grant of $1 million from the Food and Drug Administration (FDA Orphan Drugs Program). The grant will fund a Phase II Human Clinical Trial evaluating the safety and efficacy of a treatment for Leber congenital amaurosis (LCA), a genetic retinal disease known to cause blindness at an early age.

Effect of abortion restrictions in health bill may be less than advocates fear

Despite widespread debate, abortion restrictions in the House health reform bill could affect only a small number of women. Meanwhile, Catholic bishops weigh into the debate and abortion rights group plan a rally to contest the restrictions.

New microchip technology to identify neuronal regenerators

Scientists have long sought the ability to regenerate nerve cells, or neurons, which could offer a new way to treat spinal-cord damage as well as neurological diseases such as Alzheimer's or Parkinson's. Many chemicals can regenerate neurons grown in Petri dishes in the lab, but it's difficult and time-consuming to identify those chemicals that work in live animals, which is critical for developing drugs for humans.

Specific gene variation may play a role in late-onset Alzheimer's disease: New study

A new study from the Centre for Addiction and Mental Health has found evidence suggesting that a variation of a specific gene may play a role in late-onset Alzheimer's, the disease which accounts for over 90% of Alzheimer's cases. This innovative study has combined genetics and brain imaging to determine who may be at risk for developing late-onset Alzheimer's disease long before symptoms appear.

Read more Medical News

› Verified 2 days ago